6-K
Smith & Nephew PLC (SNN)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
August 13, 2025
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ✓ Form 40-F __
SMITH & NEPHEW PLC
13 August 2025
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.
1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020
On 13 August 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.
All figures in these columns are stated to 6 decimal places where applicable.
PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of shares were sold to cover taxation obligations arising on the vesting of the awards.
The following relates to individuals included in the below notification:
| Reason for the notification | ||||
|---|---|---|---|---|
| Initial<br>notification /Amendment | Initial<br>notification | |||
| Details of the issuer, emission allowance market participant,<br>auction platform, auctioneer or auction monitor | ||||
| Name | Smith<br>& Nephew plc | |||
| LEI | 213800ZTMDN8S67S1H61 | |||
| Details of the transaction(s): section to be repeated for (i) each<br>type of instrument; (ii) each type of transaction; (iii) each date;<br>and (iv) each place where transactions have been<br>conducted | ||||
| Description of the<br>financial instrument, type of instrument | Smith<br>& Nephew plc ordinary shares of USD 0.20 each | |||
| Identification<br>code | ISIN:<br>GB0009223206 | |||
| Nature<br>of the transaction | Partial<br>vesting on 12 August 2025 of Conditional Share awards granted on 11<br>August 2023 under the Smith & Nephew Global Share Plan 2020,<br>and subsequent sale of shares to cover tax liability | |||
| Date<br>of Transaction | 2025<br>- 08 - 12 | |||
| Place<br>of Transaction | London<br>Stock Exchange (XLON) | |||
| Name<br><br><br>(Position) | Status | Price (£) | Volume | Aggregated information |
| --- | --- | --- | --- | --- |
| Rohit<br>Kashyap<br><br><br>(President,<br>Advanced Wound Management and Global | PDMR | 13.571365 | 23,201<br>(of which 5,670 were sold and 17,531 were retained.) | N/A<br>Single Transaction |
Helen Barraclough
Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Smith & Nephew plc | ||
|---|---|---|
| (Registrant) | ||
| Date:<br>August 13, 2025 | By: | /s/<br>Helen Barraclough |
| Helen<br>Barraclough | ||
| Company<br>Secretary |